Profound Medical Corp(PROF-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Latest News
Profound Medical Annual General Meeting of Shareholders Voting Results
GlobeNewswire - Wed May 15, 4:00PM CDT
GlobeNewswire
Wed May 15, 4:00PM CDT
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS
Newswire.ca - Wed May 15, 3:12PM CDT
Newswire.ca
Wed May 15, 3:12PM CDT
/CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General...
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
GlobeNewswire - Tue May 14, 6:30AM CDT
GlobeNewswire
Tue May 14, 6:30AM CDT
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
GlobeNewswire - Thu May 9, 3:05PM CDT
GlobeNewswire
Thu May 9, 3:05PM CDT
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
GlobeNewswire - Mon May 6, 3:15PM CDT
GlobeNewswire
Mon May 6, 3:15PM CDT
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
GlobeNewswire - Mon Apr 22, 3:15PM CDT
GlobeNewswire
Mon Apr 22, 3:15PM CDT
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
GlobeNewswire - Tue Apr 9, 6:45AM CDT
GlobeNewswire
Tue Apr 9, 6:45AM CDT
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire - Thu Mar 7, 3:05PM CST
GlobeNewswire
Thu Mar 7, 3:05PM CST
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
GlobeNewswire - Mon Mar 4, 3:30PM CST
GlobeNewswire
Mon Mar 4, 3:30PM CST
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
GlobeNewswire - Tue Feb 27, 6:45AM CST
GlobeNewswire
Tue Feb 27, 6:45AM CST
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
GlobeNewswire - Thu Feb 15, 3:30PM CST
GlobeNewswire
Thu Feb 15, 3:30PM CST
Profound Medical Announces Non-Brokered Private Placement
GlobeNewswire - Tue Jan 16, 3:30PM CST
GlobeNewswire
Tue Jan 16, 3:30PM CST
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
GlobeNewswire - Wed Jan 3, 3:15PM CST
GlobeNewswire
Wed Jan 3, 3:15PM CST
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
GlobeNewswire - Wed Dec 27, 2023
GlobeNewswire
Wed Dec 27, 2023
Profound Medical Announces Proposed Public Offering of Common Shares
GlobeNewswire - Wed Dec 27, 2023
GlobeNewswire
Wed Dec 27, 2023
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
GlobeNewswire - Wed Nov 8, 2023
GlobeNewswire
Wed Nov 8, 2023
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
GlobeNewswire - Fri Nov 3, 2023
GlobeNewswire
Fri Nov 3, 2023
Profound Medical Announces Third Quarter 2023 Financial Results
GlobeNewswire - Thu Nov 2, 2023
GlobeNewswire
Thu Nov 2, 2023
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
GlobeNewswire - Thu Oct 19, 2023
GlobeNewswire
Thu Oct 19, 2023
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
GlobeNewswire - Tue Oct 10, 2023
GlobeNewswire
Tue Oct 10, 2023
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
GlobeNewswire - Mon Sep 25, 2023
GlobeNewswire
Mon Sep 25, 2023
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
GlobeNewswire - Thu Sep 21, 2023
GlobeNewswire
Thu Sep 21, 2023
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
GlobeNewswire - Tue Sep 19, 2023
GlobeNewswire
Tue Sep 19, 2023
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
GlobeNewswire - Wed Sep 6, 2023
GlobeNewswire
Wed Sep 6, 2023
Profound Medical Announces Second Quarter 2023 Financial Results
GlobeNewswire - Wed Aug 9, 2023
GlobeNewswire
Wed Aug 9, 2023